Liberator Medical Holdings, Inc. (LBMH) Posts Year-over-Year Improvements in Q2, FH2013

Liberator Medical Holdings reported its financial results for the second fiscal quarter and six months ended March 31, 2013, reflecting revenue and earnings growth for both periods.

Sales for second quarter of 2013 increased 14.1 percent to $16.7 million, as compared with sales of $14.6 million for the same three months of 2012. Sales for the six months ended March 31, 2013, increased by 16.4 percent to $34.2 million, as compared with sales of $29.4 million for the six months ended March 31, 2012.

Net income was $1.4 million, or $0.03 diluted earnings per share, compared with net income of $0.7 million, or $0.01 per share, for the second quarter last year. For the first six months of 2013, net income was $2.7 million, or $0.05 per share, compared to $1.1 million, or $0.02 per share, reported for the first six months of 2012.

Second-quarter income from operations increased 107.2 percent to $2.3 million, as compared to $1.1 million in the prior year period. For the first six months of 2013, income from operations increased to $4.6 million, as compared to $1.9 million in the first six months of 2012.

Net income for the second quarter of 2013 increased 112 percent to $1.4 million, as compared to $670,000 for the comparable three months of 2012. Net income for the six-month period increased 147 percent to $2.7 million, as compared to $1.1 million for the comparable six months ended March 31, 2012.

As of March 31, 2013, Liberty Medical had $7.0 million of cash and $4.3 million available from its credit line facility.

“We continue to manage the level of our direct response advertising spend to maximize profitability and cash flows for fiscal year 2013. During the first half of fiscal year 2013, we increased our sales by 16 percent, improved our operating margins to 13.4 percent of sales, and generated $4.1 million in operating cash flows for the first six months of fiscal year 2013 compared with the first six months of fiscal year 2012,” Mark Libratore, Liberator Medical’s president and CEO, stated in the press release. “We expect to continue to increase our operating margins and cash flows during the second half of fiscal year 2013 compared with fiscal year 2012.”

On April 3, 2013, the company’s board of directors approved a cash dividend of $0.02 per common share to its shareholders.

For more information, visit www.liberatormedical.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html